4.6 Article

Potential Founder Variants in COL4A4 Identified in Bukharian Jews Linked to Autosomal Dominant and Autosomal Recessive Alport Syndrome

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Urology & Nephrology

Guidelines for Genetic Testing and Management of Alport Syndrome

Judy Savige et al.

Summary: Genetic testing for pathogenic COL4A3?5 variants is crucial for investigating persistent hematuria and suspected inherited kidney diseases. Even in cases where a heterozygous pathogenic COL4A3 or COL4A4 is suspected, experts recommend genetic testing and cascade testing of family members to reduce the risk of kidney dysfunction. Testing for variants in the COL4A3?5 genes is also recommended for other kidney conditions such as proteinuria, steroid-resistant nephrotic syndrome, IgA glomerulonephritis, and kidney failure of unknown cause.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2022)

Article Multidisciplinary Sciences

Genotype-phenotype correlations for COL4A3-COL4A5 variants resulting in Gly substitutions in Alport syndrome

Joel T. Gibson et al.

Summary: This study examined the molecular characteristics of Gly substitutions in Alport syndrome and found that the stability of the substitution and its interaction with nearby residues determine the risk of haematuria, early onset kidney failure, and hearing loss in this inherited kidney disease.

SCIENTIFIC REPORTS (2022)

Review Medicine, General & Internal

Genotype-Phenotype Correlations for Pathogenic COL4A3-COL4A5 Variants in X-Linked, Autosomal Recessive, and Autosomal Dominant Alport Syndrome

Judy Savige et al.

Summary: Alport syndrome is a genetic disease caused by pathogenic variants in COL4A3 - COL4A5 genes, leading to kidney failure and hearing loss. Understanding the genotype-phenotype correlations can help predict the age of kidney failure and guide clinical management.

FRONTIERS IN MEDICINE (2022)

Review Urology & Nephrology

Alport Syndrome: Achieving Early Diagnosis and Treatment

Clifford E. Kashtan

Summary: Alport syndrome is a genetically and phenotypically heterogeneous disorder caused by mutations in collagen IV genes, leading to kidney failure, sensorineural deafness, and ocular abnormalities. Early diagnosis is crucial for optimal outcomes, but can be challenging due to the complexity of the disorder.

AMERICAN JOURNAL OF KIDNEY DISEASES (2021)

Article Urology & Nephrology

Clinical and Genetic Features of Autosomal Dominant Alport Syndrome: A Cohort Study

Monica Furlano et al.

Summary: The study evaluated the clinical and genetic spectrum of patients with autosomal dominant Alport syndrome (ADAS) in 82 families. It found that ADAS patients have a wide range of clinical presentations, with a median kidney survival of 67 years and microhematuria being the most common kidney manifestation.

AMERICAN JOURNAL OF KIDNEY DISEASES (2021)

Article Genetics & Heredity

Screening for autosomal recessive and X-linked conditions during pregnancy and preconception: a practice resource of the American College of Medical Genetics and Genomics (ACMG)

Anthony R. Gregg et al.

Summary: Carrier screening initially targeted specific genetic conditions in certain ethnic groups, but with the advancement of next-generation sequencing, panethnic screening has become possible. Understanding carrier status allows informed reproductive decisions, while standardized screening methods improve testing consistency.

GENETICS IN MEDICINE (2021)

Article Multidisciplinary Sciences

mRNA analysis identifies deep intronic variants causing Alport syndrome and overcomes the problem of negative results of exome sequencing

Xiaoyuan Wang et al.

Summary: This study identified six novel deep intronic splicing variants in COL4A4 and COL4A5 genes in four AS probands, and detected a COL4A5 variant in one proband. mRNA analysis can resolve genetic diagnosis in AS patients with negative NGS results. Urine COL4A3-5 mRNA analysis is recommended as the first choice for diagnosis.

SCIENTIFIC REPORTS (2021)

Article Multidisciplinary Sciences

The mutational constraint spectrum quantified from variation in 141,456 humans

Konrad J. Karczewski et al.

NATURE (2020)

Article Biochemistry & Molecular Biology

Predicting Splicing from Primary Sequence with Deep Learning

Kishore Jaganathan et al.

Review Pediatrics

Basement Membrane Defects in Genetic Kidney Diseases

Christine Chew et al.

FRONTIERS IN PEDIATRICS (2018)

Article Multidisciplinary Sciences

Annotating pathogenic non-coding variants in genic regions

Sahar Gelfman et al.

NATURE COMMUNICATIONS (2017)

Article Urology & Nephrology

Natural History and Genotype-Phenotype Correlation in Female X-Linked Alport Syndrome

Tomohiko Yamamura et al.

KIDNEY INTERNATIONAL REPORTS (2017)

Article Genetics & Heredity

Alport syndrome: impact of digenic inheritance in patients management

C. Fallerini et al.

CLINICAL GENETICS (2017)

Article Genetics & Heredity

The Israeli National Genetic database: a 10-year experience

Joel Zlotogora et al.

HUMAN GENOMICS (2017)

Article Genetics & Heredity

REVEL: An Ensemble Method for Predicting the Pathogenicity of Rare Missense Variants

Nilah M. Ioannidis et al.

AMERICAN JOURNAL OF HUMAN GENETICS (2016)

Article Urology & Nephrology

Genetic, Clinical, and Pathologic Backgrounds of Patients with Autosomal Dominant Alport Syndrome

Naohiro Kamiyoshi et al.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)

Article Genetics & Heredity

Evidence of digenic inheritance in Alport syndrome

Maria Antonietta Mencarelli et al.

JOURNAL OF MEDICAL GENETICS (2015)

Editorial Material Genetics & Heredity

Genetics and genomic medicine in Israel

Joel Zlotogora

MOLECULAR GENETICS & GENOMIC MEDICINE (2014)

Article Urology & Nephrology

Expert Guidelines for the Management of Alport Syndrome and Thin Basement Membrane Nephropathy

Judy Savige et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2013)

Review Transplantation

Molecular genetics of familial hematuric diseases

Constantinos Deltas et al.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2013)

Article Urology & Nephrology

Thin basement membrane nephropathy

J Savige et al.

KIDNEY INTERNATIONAL (2003)